Cargando…

Defining Anti-arrhythmic Efficacy in the Setting of Evolving Concepts About Atrial Fibrillation

Detalles Bibliográficos
Autor principal:	Reiffel, James A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MediaSphere Medical 2023
Materias:	Expert Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10198297/ https://www.ncbi.nlm.nih.gov/pubmed/37213893 http://dx.doi.org/10.19102/icrm.2023.14016

Ejemplares similares

Selected Advancements in the Management of Atrial Fibrillation from the Year 2021
por: Reiffel, James A.
Publicado: (2022)

Considerations Regarding the Periprocedural Use of Oral Anticoagulation Therapy in Patients Undergoing Atrial Fibrillation Ablation
por: Reiffel, James A.
Publicado: (2018)

The State of Atrial Fibrillation in 2020
por: Doshi, Rahul N
Publicado: (2021)

Oral Anticoagulant Therapy: When What Should Not Be Is and What Should Be Is Not
por: Reiffel, James A.
Publicado: (2019)

Adverse Events with Amiodarone—Will the List Ever End?
por: Reiffel, James A.
Publicado: (2018)

Going Beyond Antiarrhythmic–Anticoagulant Drug Interactions: Considerations in the Complex Medicated Patient
por: Reiffel, James A.
Publicado: (2019)

Reduced-dose Antiarrhythmic Drugs: Valuable or Valueless?
por: Reiffel, James A.
Publicado: (2020)

“Ranolaziodarone”—A Synergism You Should Not Miss
por: Reiffel, James A.
Publicado: (2021)

Atrial Fibrillation: The Year of 2021 in Review
por: Sardana, Mayank, et al.
Publicado: (2022)

A Year in Review: Atrial Fibrillation 2022
por: Sardana, Mayank, et al.
Publicado: (2023)

Posterior Wall Isolation for Atrial Fibrillation: Excessive or Necessary?
por: Doshi, Rahul N.
Publicado: (2018)

Highlights from Heart Rhythm 2019: Atrial Fibrillation
por: Doshi, Rahul N.
Publicado: (2019)

Highlights from Heart Rhythm 2018: Atrial Fibrillation
por: Doshi, Rahul N.
Publicado: (2018)

Nurse-directed Preventative Management of Atrial Fibrillation: Is it Feasible?
por: Huntsinger, Mary E., et al.
Publicado: (2019)

More Evidence for Isolation of the Left Atrial Free Wall During the Convergent Procedure in Atrial Fibrillation
por: Kiser, Andy C.
Publicado: (2018)

Atrial Fibrillation Ablation Without Fluoroscopy: Because We Can
por: Doshi, Rahul N.
Publicado: (2018)

Considering the Cryoballoon as a Multifaceted Tool for Extensive Left Atrial Ablation in Patients with Longstanding Persistent Atrial Fibrillation
Publicado: (2022)

The Nexus of Atrial Fibrillation, Heart Failure, and Cardiac Pacing Therapies in 2022
por: Niazi, Imran
Publicado: (2023)

Safety and Efficacy of Dronedarone in the Treatment of Atrial Fibrillation/Flutter
por: Naccarelli, Gerald V., et al.
Publicado: (2011)

Oral Anticoagulants for Newly Detected Atrial Fibrillation in Cryptogenic Stroke Patients: Still a Bitter Pill to Swallow Quickly
por: Doshi, Rahul N., et al.
Publicado: (2021)

Novel Anti-arrhythmic Medications in the Treatment of Atrial Fibrillation
por: Saklani, Pradyot, et al.
Publicado: (2012)

Anti-arrhythmic drugs in atrial fibrillation: tailor-made treatments
por: Capucci, Alessandro, et al.
Publicado: (2023)

Concerns about clinical efficacy and safety of warfarin in diabetic patients with atrial fibrillation
por: Yamagishi, Sho-ichi
Publicado: (2019)

Microelectrodes for Atrial Flutter: Bringing a Scalpel to a Gun Fight
por: Doshi, Rahul N.
Publicado: (2018)

A Standardised Protocol for Evaluation of Anthelminthic Efficacy
por: Horton, John
Publicado: (2011)

Through the Looking Glass: Chronic Urticaria Treated with Anti-IgE Therapy
por: Pajno, Giovanni B.
Publicado: (2016)

Oral Anticoagulation and Antiarrhythmic Drug Therapy for Atrial Fibrillation
por: Reiffel, James A.
Publicado: (2018)

Clinical and economic outcomes associated with use of anti-arrhythmic drugs versus ablation in atrial fibrillation
por: Ken-Opurum, Jennifer, et al.
Publicado: (2023)

When Silence Isn’t Golden: The Case of “Silent” Atrial Fibrillation
por: Reiffel, James A.
Publicado: (2017)

Defining the concept of locally advanced squamous cell carcinoma of the vulva: a new perspective based on standardization of criteria and current evidence
por: Aragona, Alejandro M., et al.
Publicado: (2014)

Editorial: Advances in The Therapy of Atrial Fibrillation: Incrementally Progressive But Not Without Missteps
por: Reiffel, James A
Publicado: (2014)

In silico study of the effects of anti-arrhythmic drug treatment on sinoatrial node function for patients with atrial fibrillation
por: Bai, Jieyun, et al.
Publicado: (2020)

Atrial fibrillation progression: another step in the RACE to full understanding
por: Capucci, Alessandro, et al.
Publicado: (2023)

Inhaled β(2)-agonists in asthma management: an evolving story
por: Silva, Diana, et al.
Publicado: (2016)

Ivermectin Resistance in Onchocerca volvulus: Toward a Genetic Basis
por: Lustigman, Sara, et al.
Publicado: (2007)

Atrial Remodeling: Evolving Concepts
por: Biffi, Mauro, et al.
Publicado: (2003)

A European Perspective on Topical Ophthalmic Antibiotics: Current and Evolving Options
por: Bremond-Gignac, D., et al.
Publicado: (2011)

Evolving Management Trends and Outcomes in Catheter Management of Acute Pulmonary Embolism
por: Lewis, Alexander E., et al.
Publicado: (2022)

Propofol in ICU Settings: Understanding and Managing Anti-Arrhythmic, Pro-Arrhythmic Effects, and Propofol Infusion Syndrome
por: Paramsothy, Jananthan, et al.
Publicado: (2023)

Atrial Heterogeneity Generates Re-entrant Substrate during Atrial Fibrillation and Anti-arrhythmic Drug Action: Mechanistic Insights from Canine Atrial Models
por: Varela, Marta, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_4g0569kk31hg17itunl83rnhuu